Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1967 2
1968 1
1969 1
1970 2
1971 3
1972 1
1973 2
1975 2
1976 1
1977 2
1978 1
1981 6
1982 2
1983 1
1984 3
1985 4
1986 2
1987 1
1988 2
1989 4
1990 10
1991 3
1992 2
1993 2
1995 4
1996 7
1997 5
1998 6
1999 6
2000 7
2001 8
2002 4
2003 6
2004 8
2005 9
2006 9
2007 10
2008 8
2009 4
2010 17
2011 10
2012 14
2013 12
2014 16
2015 10
2016 17
2017 18
2018 8
2019 9
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

274 results
Results by year
Filters applied: . Clear all
Page 1
Neonatal characteristics and perinatal complications in neonates with Down syndrome.
Ergaz-Shaltiel Z, Engel O, Erlichman I, Naveh Y, Schimmel MS, Tenenbaum A. Ergaz-Shaltiel Z, et al. Am J Med Genet A. 2017 May;173(5):1279-1286. doi: 10.1002/ajmg.a.38165. Epub 2017 Apr 6. Am J Med Genet A. 2017. PMID: 28386951
Mortality during the primary hospitalization was 3.7%. The most common anomalies were cardiac (79%) with either congenital defects or functional abnormalities, neither influenced the length of hospitalization. ...
Mortality during the primary hospitalization was 3.7%. The most common anomalies were cardiac (79%) with either congenital defects or
Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial.
Uffmann M, Rasche M, Zimmermann M, von Neuhoff C, Creutzig U, Dworzak M, Scheffers L, Hasle H, Zwaan CM, Reinhardt D, Klusmann JH. Uffmann M, et al. Blood. 2017 Jun 22;129(25):3314-3321. doi: 10.1182/blood-2017-01-765057. Epub 2017 Apr 11. Blood. 2017. PMID: 28400376 Clinical Trial.
Still, 5-year overall survival (89% ± 3% vs 90% ± 4%; P(log-rank) = .64), event-free survival (EFS; 87% ± 3% vs 89% ± 4%; P(log-rank) = .71), and cumulative incidence of relapse/nonresponse (CIR/NR; 6% ± 3% vs 6% ± 2%; P(Gray) = .03) did not significantly differ bet …
Still, 5-year overall survival (89% ± 3% vs 90% ± 4%; P(log-rank) = .64), event-free survival (EFS; 87% ± 3% vs 89% ± 4%; P(lo …
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial.
Taub JW, Berman JN, Hitzler JK, Sorrell AD, Lacayo NJ, Mast K, Head D, Raimondi S, Hirsch B, Ge Y, Gerbing RB, Wang YC, Alonzo TA, Campana D, Coustan-Smith E, Mathew P, Gamis AS. Taub JW, et al. Blood. 2017 Jun 22;129(25):3304-3313. doi: 10.1182/blood-2017-01-764324. Epub 2017 Apr 7. Blood. 2017. PMID: 28389462 Free PMC article. Clinical Trial.
Patients with myeloid leukemia of Down syndrome (ML-DS) have favorable event-free survival (EFS), but experience significant treatment-related morbidity and mortality. ...The Children's Oncology Group (COG) AAML0431 trial consisted of 4 cycles of induction an …
Patients with myeloid leukemia of Down syndrome (ML-DS) have favorable event-free survival (EFS), but experience significant treatmen …
Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
Bista R, Lee DW, Pepper OB, Azorsa DO, Arceci RJ, Aleem E. Bista R, et al. J Exp Clin Cancer Res. 2017 Feb 1;36(1):22. doi: 10.1186/s13046-017-0493-5. J Exp Clin Cancer Res. 2017. PMID: 28143565 Free PMC article.
BTZ-resistance conferred increased resistance to Ara-C due to G1 arrest in the CMY-BR cells, which protected the cells from S-phase damage by Ara-C. ...
BTZ-resistance conferred increased resistance to Ara-C due to G1 arrest in the CMY-BR cells, which protected the cells from S-phase d …
Characteristics and survival of children with acute leukemia with Down syndrome or other birth defects in New York State.
Qiao B, Austin AA, Schymura MJ, Browne ML. Qiao B, et al. Cancer Epidemiol. 2018 Dec;57:68-73. doi: 10.1016/j.canep.2018.10.004. Epub 2018 Oct 13. Cancer Epidemiol. 2018. PMID: 30326394
Survivals were similar among three groups. Among 563 AML children, 11.0% had DS, 6.0% had other birth defects, and 83.0% had no birth defects. ...Comparable survival was observed for ALL children. However, AML children with DS demonstrated superior survival c
Survivals were similar among three groups. Among 563 AML children, 11.0% had DS, 6.0% had other birth defects, and 83.0% had no birth
Craniofacial disorders associated with airway obstruction in the neonate.
Cielo CM, Montalva FM, Taylor JA. Cielo CM, et al. Semin Fetal Neonatal Med. 2016 Aug;21(4):254-62. doi: 10.1016/j.siny.2016.03.001. Epub 2016 Mar 17. Semin Fetal Neonatal Med. 2016. PMID: 26997148 Free PMC article. Review.
In infants with craniofacial disorders, upper airway obstruction is one of the primary causes for morbidity and mortality in the neonatal period. ...
In infants with craniofacial disorders, upper airway obstruction is one of the primary causes for morbidity and mortality in the neon …
Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y, Shiba N, Ohki K, Tabuchi K, Yamato G, Park MJ, Tomizawa D, Kinoshita A, Shimada A, Arakawa H, Saito AM, Kiyokawa N, Tawa A, Horibe K, Taga T, Adachi S, Taki T, Hayashi Y. Hara Y, et al. Genes Chromosomes Cancer. 2017 May;56(5):394-404. doi: 10.1002/gcc.22444. Epub 2017 Feb 14. Genes Chromosomes Cancer. 2017. PMID: 28063190
Four-year overall survival (OS) and event-free survival (EFS) rates of CBFA2T3-GLIS2-positive patients in AMKL were 41.7% and 16.7%, respectively. ...
Four-year overall survival (OS) and event-free survival (EFS) rates of CBFA2T3-GLIS2-positive patients in AMKL were 41.7% and …
Cardiac transplantation in children with Down syndrome, Turner syndrome, and other chromosomal anomalies: A multi-institutional outcomes analysis.
Broda CR, Cabrera AG, Rossano JW, Jefferies JL, Towbin JA, Chin C, Shamszad P. Broda CR, et al. J Heart Lung Transplant. 2018 Jun;37(6):749-754. doi: 10.1016/j.healun.2018.01.1296. Epub 2018 Jan 31. J Heart Lung Transplant. 2018. PMID: 29449075 Clinical Trial.
METHODS: A query of the database of the Pediatric Health Information System, a large administrative and billing database of 43 tertiary children's hospitals, was performed for the Years 2004 to 2016. ...The presence of CA did not confer a higher risk of in-hospital mort
METHODS: A query of the database of the Pediatric Health Information System, a large administrative and billing database of 43 tertiary chil …
Down syndrome: perinatal mortality risks with each additional week of expectant management.
Sparks TN, Griffin E, Page J, Pilliod R, Shaffer BL, Caughey AB. Sparks TN, et al. Prenat Diagn. 2016 Apr;36(4):368-74. doi: 10.1002/pd.4792. Epub 2016 Mar 14. Prenat Diagn. 2016. PMID: 26891366
OBJECTIVE: To evaluate the gestational age (GA) at which perinatal mortality risk is minimized for fetuses with Down syndrome (DS). ...Comparing mortality with expectant management to delivery, expectant management carried increasing risk from 38 (RR 1.18; 95% CI 1. …
OBJECTIVE: To evaluate the gestational age (GA) at which perinatal mortality risk is minimized for fetuses with Down syndrome (DS). . …
274 results
Jump to page
Feedback